Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 1998, p. 5699-5711, Vol. 18, No. 10
Chiron Corporation, Emeryville, California
94608
Received 26 March 1998/Returned for modification 5 May
1998/Accepted 21 July 1998
Using a new inducible form of phosphatidylinositol 3-kinase (PI
3-kinase) we have found that PI 3-kinase activation has the following
effects on cell growth and proliferation. (i) Activation of PI 3-kinase
was sufficient to promote entry into S phase of the cell cycle within
several hours. This was shown by activation of cyclin-dependent kinase
4 (Cdk4) and Cdk2 and by the induction of DNA synthesis. (ii) PI
3-kinase activation alone was not, however, sufficient to provide for
progression through the entire cell cycle. Instead, prolonged
activation of PI 3-kinase in the absence of serum stimulation resulted
in apoptosis. It is possible that the cells undergo apoptosis because
the PI 3-kinase-induced entry into the cell cycle is abnormal. For
example, we found that the cyclin E-Cdk2 complex, which normally
disappears after entry into S phase of the cell cycle, fails to be
downregulated following induction by PI 3-kinase. (iii) Finally, we
found that prolonged activation of PI 3-kinase in the presence of serum
resulted in cellular changes that resemble those associated with
oncogenic transformation. The cells reached high densities, were
irregular and refractile in appearance, and formed colonies in soft
agar. In contrast, neither PI 3-kinase nor serum stimulation alone
could induce these changes. Our results suggest that activation of PI 3-kinase promotes anchorage-independent cell growth and entry into the
cell cycle but does not abrogate the growth factor requirement for cell
proliferation.
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Activation of Phosphatidylinositol 3-Kinase Is
Sufficient for Cell Cycle Entry and Promotes Cellular Changes
Characteristic of Oncogenic Transformation
*
Corresponding author. Mailing address: Chiron
Corporation, 4560 Horton St., LSC 4.506, Emeryville, CA 94608. Phone:
(510) 923-4025. Fax: (510) 923-4115. E-mail:
anke_klippel{at}cc.chiron.com.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|